Polaryx Therapeutics is set to present new late-breaking data for its investigational therapy PLX-200 at the 2026 WORLDSymposium, bolstering confidence in the upcoming launch of its Phase 2 Soteria trial targeting multiple rare neurodegenerative disorders.
Roth Capital has shifted its rating on Coterra Energy to Neutral, citing a reduced price target and skepticism about a superior takeover offer emerging to challenge Devon Energy's current bid.
DA Davidson has upgraded Q2 Holdings (QTWO) to 'Buy,' citing an attractive valuation following a multi-month share price pullback. The firm maintains an $82 price target and projects solid organic revenue growth for the digital banking platform provider.
JPMorgan has increased its price target for Tyson Foods (TSN) to $67, up from $63, while maintaining a Neutral rating. The adjustment follows the company's latest earnings, which highlighted persistent struggles in its beef segment alongside brighter spots in other divisions.
Blockchain intelligence firm TRM Labs has achieved a $1 billion valuation after closing a $70 million Series C funding round. The investment, spearheaded by Blockchain Capital with backing from major financial institutions, underscores the growing criticality of crypto compliance tools as digital assets enter the mainstream.
The investment manager has agreed to purchase a seven-project solar portfolio across England and Scotland, significantly boosting its renewable energy assets and deepening an existing partnership with the Greek energy group.
Shares of New Jersey Resources (NJR) have climbed over 12% in the past month, closing at $51.81 and prompting investors to reassess the utility's fair value against a backdrop of steady growth and regulatory risks.
While Visa's stock has underperformed the S&P 500 in the past year, a deep dive into its fundamentals and analyst sentiment reveals a starkly optimistic outlook on the payments giant.
Accounting for a quarter of foodservice sales, the humble sandwich is a powerhouse for c-stores. With sales projected to hit $8.6 billion by 2029, operators are innovating with fresh ingredients, strategic variety, and operational savvy to capture more of this lucrative market.
Amgen pushes back against regulators seeking to pull a key drug, while Pfizer faces investor skepticism over its obesity candidate. Meanwhile, Merck details an ambitious plan to offset the looming patent cliff of its blockbuster Keytruda and reach $70 billion in annual sales.
Israeli airstrikes and artillery fire hit multiple areas of the Gaza Strip on Wednesday, killing at least 17 Palestinians. The military said the operation was a response to an attack that seriously wounded an Israeli soldier near a sensitive border zone.
Shares of biometric security firm Clear Secure have retreated nearly 8% this month, sparking debate among investors. While the stock remains up significantly over the past year, a deep dive into valuation metrics suggests the recent weakness may have created an attractive entry point for long-term investors.
Analysts have nudged the fair value estimate for pharmaceutical player Laurus Labs higher by approximately 6%, a move interpreted less as a major revision and more as a reaffirmation of faith in the company's existing growth trajectory.
Healthpeak Properties reported robust Q4 2025 results, beating estimates and announcing an IPO for its senior housing REIT, Janus Living. However, the stock fell sharply as investors weighed cautious forward guidance against long-term strategic shifts.
After recent share price declines, Niagen Bioscience is drawing renewed investor scrutiny. The biotech firm's valuation story hinges on its proprietary NAD+ technology, upcoming B2B product launches, and critical clinical data readouts expected later this year.
Amid market jitters over AI monetization, chip giants Micron Technology and Taiwan Semiconductor Manufacturing present a case for strategic investment, backed by strong fundamentals and critical roles in the AI supply chain.
Kratos Defense & Security Solutions wins new contracts worth approximately $65 million to provide advanced training systems for U.S. and allied military aircraft, highlighting its growing role in cost-effective, high-tech defense simulation.
For the first time in roughly two decades, Taiwan has surpassed mainland China as the largest country weighting in the MSCI Emerging Markets Index. The shift, driven by the outperformance of Taiwan's AI-focused tech giants, underscores the immense influence of benchmark providers on global capital allocation and spotlights a significant realignment within emerging markets.
Fintech firm Sezzle is fundamentally reshaping its 'buy now, pay later' proposition, launching a subscription ecosystem and a merchant-agnostic virtual card. The strategic shift comes as regulatory pressures on the sector lessen, potentially altering its competitive stance against giants like Affirm and Klarna.
Shares of Lithium Americas (TSX:LAC) fell sharply following the formalization of new funding agreements with the Department of Energy and General Motors for the Thacker Pass project. The deals grant the DOE discounted warrants and a stake in the venture, reshaping its capital structure and cementing federal involvement, while raising fresh questions about dilution and execution risks for the pre-revenue miner.
